Distinct patterns of activation-dependent changes in conformational mobility between ERK1 and ERK2.

[1]  J. Settleman,et al.  Targeting the RAF-MEK-ERK pathway in cancer therapy. , 2009, Cancer letters.

[2]  Koichi Yokota,et al.  Crystal structure of human mono-phosphorylated ERK1 at Tyr204. , 2008, Biochemical and biophysical research communications.

[3]  K. Resing,et al.  Hydrogen-exchange mass spectrometry reveals activation-induced changes in the conformational mobility of p38alpha MAP kinase. , 2008, Journal of molecular biology.

[4]  K. Resing,et al.  The gatekeeper residue controls autoactivation of ERK2 via a pathway of intramolecular connectivity , 2006, Proceedings of the National Academy of Sciences.

[5]  J. Baselga,et al.  Targeting Tyrosine Kinases in Cancer: The Second Wave , 2006, Science.

[6]  K. Resing,et al.  Protein Hydrogen Exchange Measured by Electrospray Ionization Mass Spectrometry , 2006 .

[7]  K. Resing,et al.  Hydrogen exchange solvent protection by an ATP analogue reveals conformational changes in ERK2 upon activation. , 2005, Journal of molecular biology.

[8]  N. Ahn,et al.  Phosphorylation-dependent changes in structure and dynamics in ERK2 detected by SDSL and EPR. , 2004, Biophysical journal.

[9]  Wei Li,et al.  Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Goldsmith,et al.  Changes in protein conformational mobility upon activation of extracellular regulated protein kinase-2 as detected by hydrogen exchange. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Wilsbacher,et al.  Bacterial expression of activated mitogen-activated protein kinases. , 2001, Methods in enzymology.

[12]  J. Pouysségur,et al.  Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. , 1999, Science.

[13]  K. Wilson,et al.  The structure of phosphorylated p38gamma is monomeric and reveals a conserved activation-loop conformation. , 1999, Structure.

[14]  K. Resing,et al.  Modeling deuterium exchange behavior of ERK2 using pepsin mapping to probe secondary structure , 1999, Journal of the American Society for Mass Spectrometry.

[15]  K. Wilson,et al.  A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase , 1998, Protein science : a publication of the Protein Society.

[16]  N. Ahn,et al.  Deuterium exchange mass spectrometry as a probe of protein kinase activation. Analysis of wild-type and constitutively active mutants of MAP kinase kinase-1. , 1998, Biochemistry.

[17]  Elizabeth J. Goldsmith,et al.  Activation Mechanism of the MAP Kinase ERK2 by Dual Phosphorylation , 1997, Cell.

[18]  E. Goldsmith,et al.  The structure of mitogen-activated protein kinase p38 at 2.1-A resolution. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. E. Celis,et al.  Cell Biology: A Laboratory Handbook , 1997 .

[20]  Paul R. Caron,et al.  Crystal Structure of p38 Mitogen-activated Protein Kinase* , 1996, The Journal of Biological Chemistry.

[21]  Elizabeth J. Goldsmith,et al.  Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution , 1994, Nature.

[22]  M. Cobb,et al.  Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro. , 1993, The Journal of biological chemistry.